Related Experiment Video

Updated: Jan 24, 2026

Measurement of Scattering Nonlinearities from a Single Plasmonic Nanoparticle
15:06

Measurement of Scattering Nonlinearities from a Single Plasmonic Nanoparticle

Published on: January 3, 2016

13.4K

Large optical nonlinearity of ITO/Ag/ITO sandwiches based on Z-scan measurement

Ke Wu, Zhewei Wang, Jianhan Yang

    Optics Letters
    |May 16, 2019
    PubMed

    More Related Videos

    Implementation of a Nonlinear Microscope Based on Stimulated Raman Scattering09:13

    Implementation of a Nonlinear Microscope Based on Stimulated Raman Scattering

    Published on: July 6, 2019

    8.0K
    Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy07:13

    Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy

    Published on: May 16, 2022

    2.3K

    Related Concept Videos

    Nonlinear Pharmacokinetics: Causes of Nonlinearity01:22

    Nonlinear Pharmacokinetics: Causes of Nonlinearity

    Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
    Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
    719
    Nonlinear Pharmacokinetics: Overview01:19

    Nonlinear Pharmacokinetics: Overview

    Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
    Nonlinearity can arise due to the saturation of plasma protein-binding or...
    1.1K
    Leaky Scanning02:28

    Leaky Scanning

    During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
    5.7K
    Nonlinear Pharmacokinetics: Michaelis-Menten Equation01:18

    Nonlinear Pharmacokinetics: Michaelis-Menten Equation

    The Michaelis–Menten equation is a fundamental model for describing capacity-limited kinetics in drug metabolism. It offers insights into the rate of decline of plasma drug concentration Cp over time, with Vmax and KM as pivotal parameters.
    Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
    1.1K
    Nonlinear Pharmacokinetics: Role of Transporters01:27

    Nonlinear Pharmacokinetics: Role of Transporters

    A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
    Polymorphisms occurring in drug transporters can alter...
    289
    Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding01:22

    Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding

    When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
    To quantify the extent of bioavailability, pharmacologists often use a parameter called .
    606